Muhammed A. Saad

1.1k total citations
45 papers, 896 citations indexed

About

Muhammed A. Saad is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Neurology. According to data from OpenAlex, Muhammed A. Saad has authored 45 papers receiving a total of 896 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cellular and Molecular Neuroscience, 9 papers in Molecular Biology and 8 papers in Neurology. Recurrent topics in Muhammed A. Saad's work include Neuroinflammation and Neurodegeneration Mechanisms (7 papers), Neuroscience and Neuropharmacology Research (5 papers) and Medicinal Plants and Neuroprotection (4 papers). Muhammed A. Saad is often cited by papers focused on Neuroinflammation and Neurodegeneration Mechanisms (7 papers), Neuroscience and Neuropharmacology Research (5 papers) and Medicinal Plants and Neuroprotection (4 papers). Muhammed A. Saad collaborates with scholars based in Egypt, United Arab Emirates and Saudi Arabia. Muhammed A. Saad's co-authors include Ayman E. El-Sahar, Rania M. Abdelsalam, Muhammad Y. Al‐Shorbagy, Hany H. Arab, Amina S. Attia, Sanaa A. Kenawy, Rabab H. Sayed, Noha F. Abdelkader, Eman M. Elbaz and Mahmoud A. Senousy and has published in prestigious journals such as Scientific Reports, Journal of Neurochemistry and Archives of Biochemistry and Biophysics.

In The Last Decade

Muhammed A. Saad

40 papers receiving 889 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Muhammed A. Saad Egypt 19 321 142 124 122 95 45 896
Ayman E. El-Sahar Egypt 19 260 0.8× 132 0.9× 97 0.8× 76 0.6× 87 0.9× 36 793
Abdelaziz M. Hussein Egypt 20 387 1.2× 153 1.1× 159 1.3× 149 1.2× 82 0.9× 83 1.2k
Rabab H. Sayed Egypt 19 308 1.0× 139 1.0× 64 0.5× 99 0.8× 105 1.1× 54 828
Liping Xu China 20 670 2.1× 145 1.0× 73 0.6× 231 1.9× 99 1.0× 53 1.3k
Hui Fu China 21 497 1.5× 107 0.8× 50 0.4× 185 1.5× 88 0.9× 52 1.2k
Qingjie Chen China 16 359 1.1× 58 0.4× 86 0.7× 171 1.4× 123 1.3× 42 889
Ana Karolina Santana Nunes Brazil 13 313 1.0× 88 0.6× 57 0.5× 162 1.3× 193 2.0× 17 804
Chenghua Zhou China 23 404 1.3× 153 1.1× 99 0.8× 327 2.7× 116 1.2× 59 1.3k
Leila Khalaj Iran 12 430 1.3× 112 0.8× 50 0.4× 179 1.5× 177 1.9× 22 864

Countries citing papers authored by Muhammed A. Saad

Since Specialization
Citations

This map shows the geographic impact of Muhammed A. Saad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Muhammed A. Saad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Muhammed A. Saad more than expected).

Fields of papers citing papers by Muhammed A. Saad

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Muhammed A. Saad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Muhammed A. Saad. The network helps show where Muhammed A. Saad may publish in the future.

Co-authorship network of co-authors of Muhammed A. Saad

This figure shows the co-authorship network connecting the top 25 collaborators of Muhammed A. Saad. A scholar is included among the top collaborators of Muhammed A. Saad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Muhammed A. Saad. Muhammed A. Saad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Saad, Muhammed A., et al.. (2025). The GLP-1 agonist semaglutide ameliorates cognitive regression in P301S tauopathy mice model via autophagy/ACE2/SIRT1/FOXO1-Mediated Microglia Polarization. European Journal of Pharmacology. 991. 177305–177305. 4 indexed citations
2.
Al‐Shorbagy, Muhammad Y., et al.. (2025). Enhancing mood post-bariatric surgery: Associations of rosuvastatin with vitamin D, oxidative stress, and neurotransmitter-related outcomes in rats. Biomedicine & Pharmacotherapy. 192. 118582–118582.
4.
Ahmed, Esraa A., et al.. (2023). Natural angiotensin converting enzyme inhibitors: A safeguard against hypertension, respiratory distress syndrome, and chronic kidney diseases. Phytotherapy Research. 37(12). 5464–5472. 11 indexed citations
5.
Arab, Hany H., Ahmed M. Ashour, Azza A. K. El‐Sheikh, et al.. (2023). Stimulation of Autophagy by Dapagliflozin Mitigates Cadmium-Induced Testicular Dysfunction in Rats: The Role of AMPK/mTOR and SIRT1/Nrf2/HO-1 Pathways. Pharmaceuticals. 16(7). 1006–1006. 15 indexed citations
6.
Arab, Hany H., Ahmed H. Eid, Ahmed M. Ashour, et al.. (2023). Targeting Autophagy, Apoptosis, and SIRT1/Nrf2 Axis with Topiramate Underlies Its Neuroprotective Effect against Cadmium-Evoked Cognitive Deficits in Rats. Pharmaceuticals. 16(9). 1214–1214. 8 indexed citations
7.
Sayed, Rabab H., et al.. (2023). Roflumilast ameliorates ovariectomy-induced depressive-like behavior in rats via activation of AMPK/mTOR/ULK1-dependent autophagy pathway. Life Sciences. 327. 121806–121806. 13 indexed citations
10.
Saad, Muhammed A., et al.. (2022). Linagliptin ameliorates acetic acid-induced colitis via modulating AMPK/SIRT1/PGC-1α and JAK2/STAT3 signaling pathway in rats. Toxicology and Applied Pharmacology. 438. 115906–115906. 27 indexed citations
11.
Ismail, Ashraf A., et al.. (2022). Dapagliflozin diminishes memory and cognition impairment in Streptozotocin induced diabetes through its effect on Wnt/β-Catenin and CREB pathway. Brain Research Bulletin. 181. 109–120. 14 indexed citations
12.
El-Shamarka, Marwa El-Sayed, Ayman E. El-Sahar, Muhammed A. Saad, Naglaa Assaf, & Rabab H. Sayed. (2022). Inosine attenuates 3-nitropropionic acid-induced Huntington's disease-like symptoms in rats via the activation of the A2AR/BDNF/TrKB/ERK/CREB signaling pathway. Life Sciences. 300. 120569–120569. 29 indexed citations
13.
Saad, Muhammed A., Muhammad Y. Al‐Shorbagy, & Hany H. Arab. (2022). Targeting the TLR4/NF-κΒ Axis and NLRP1/3 Inflammasomes by Rosuvastatin: A Role in Impeding Ovariectomy-Induced Cognitive Decline Neuropathology in Rats. Molecular Neurobiology. 59(7). 4562–4577. 9 indexed citations
14.
Arab, Hany H., Muhammad Y. Al‐Shorbagy, & Muhammed A. Saad. (2021). Activation of autophagy and suppression of apoptosis by dapagliflozin attenuates experimental inflammatory bowel disease in rats: Targeting AMPK/mTOR, HMGB1/RAGE and Nrf2/HO-1 pathways. Chemico-Biological Interactions. 335. 109368–109368. 113 indexed citations
19.
Saad, Muhammed A., Rania M. Abdelsalam, Sanaa A. Kenawy, & Amina S. Attia. (2014). Pinocembrin attenuates hippocampal inflammation, oxidative perturbations and apoptosis in a rat model of global cerebral ischemia reperfusion. Pharmacological Reports. 67(1). 115–122. 75 indexed citations
20.
Saad, Muhammed A., et al.. (2012). Potential effects of yohimbine and sildenafil on erectile dysfunction in rats. European Journal of Pharmacology. 700(1-3). 127–133. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026